544 related articles for article (PubMed ID: 33503547)
1. Systemic thrombosis in a large cohort of COVID-19 patients despite thromboprophylaxis: A retrospective study.
Muñoz-Rivas N; Abad-Motos A; Mestre-Gómez B; Sierra-Hidalgo F; Cortina-Camarero C; Lorente-Ramos RM; Torres-Rubio P; Arranz-García P; Franco-Moreno AI; Gómez-Mariscal E; Mauleón-Fernández C; Alonso-García S; Rogado J; Saez-Vaquero T; Such-Diaz A; Ryan P; Moya-Mateo E; Martín-Navarro JA; Hernández-Rivas JA; Torres-Macho J; Churruca J;
Thromb Res; 2021 Mar; 199():132-142. PubMed ID: 33503547
[TBL] [Abstract][Full Text] [Related]
2. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy.
Lodigiani C; Iapichino G; Carenzo L; Cecconi M; Ferrazzi P; Sebastian T; Kucher N; Studt JD; Sacco C; Bertuzzi A; Sandri MT; Barco S;
Thromb Res; 2020 Jul; 191():9-14. PubMed ID: 32353746
[TBL] [Abstract][Full Text] [Related]
3. The impact of protocol-based high-intensity pharmacological thromboprophylaxis on thrombotic events in critically ill COVID-19 patients.
Atallah B; Sadik ZG; Salem N; El Nekidy WS; Almahmeed W; Park WM; Cherfan A; Hamed F; Mallat J
Anaesthesia; 2021 Mar; 76(3):327-335. PubMed ID: 33047335
[TBL] [Abstract][Full Text] [Related]
4. Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations-State-of-the-Art.
Dimakakos E; Gomatou G; Catalano M; Olinic DM; Spyropoulos AC; Falanga A; Maraveyas A; Liew A; Schulman S; Belch J; Gerotziafas G; Marschang P; Cosmi B; Spaak J; Syrigos K;
Anticancer Res; 2022 Jul; 42(7):3261-3274. PubMed ID: 35790272
[TBL] [Abstract][Full Text] [Related]
5. Fatal Disseminated Intravascular Coagulopathy in Covid-19: A Small Case Series.
Kazmi S; Herekar F; Sarfaraz S
Semin Thromb Hemost; 2021 Jun; 47(4):427-430. PubMed ID: 33336328
[No Abstract] [Full Text] [Related]
6. Prophylactic anticoagulants for people hospitalised with COVID-19.
Flumignan RL; Tinôco JDS; Pascoal PI; Areias LL; Cossi MS; Fernandes MI; Costa IK; Souza L; Matar CF; Tendal B; Trevisani VF; Atallah ÁN; Nakano LC
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013739. PubMed ID: 33502773
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a patient specific, targeted-intensity pharmacologic thromboprophylaxis protocol in hospitalized patients with COVID-19.
Farrar JE; Trujillo TC; Mueller SW; Beltran L; Nguyen C; Hassell K; Kiser TH
J Thromb Thrombolysis; 2022 Feb; 53(2):446-453. PubMed ID: 34410561
[TBL] [Abstract][Full Text] [Related]
8. Incidence of thrombotic complications in hospitalised and non-hospitalised patients after COVID-19 diagnosis.
Tholin B; Ghanima W; Einvik G; Aarli B; Brønstad E; Skjønsberg OH; Stavem K
Br J Haematol; 2021 Aug; 194(3):542-546. PubMed ID: 34028814
[TBL] [Abstract][Full Text] [Related]
9. Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis.
Langer F; Kluge S; Klamroth R; Oldenburg J
Hamostaseologie; 2020 Aug; 40(3):264-269. PubMed ID: 32498097
[TBL] [Abstract][Full Text] [Related]
10. Prevention and treatment of COVID-19-associated hypercoagulability: Recommendations of the Algerian society of transfusion and hemobiology.
Chekkal M; Deba T; Hadjali S; Lamara H; Oulaa H; Zouai K; Hariti G
Transfus Clin Biol; 2020 Nov; 27(4):203-206. PubMed ID: 33022374
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 versus HIT hypercoagulability.
Warkentin TE; Kaatz S
Thromb Res; 2020 Dec; 196():38-51. PubMed ID: 32841919
[TBL] [Abstract][Full Text] [Related]
12. Non-severe COVID-19 is associated with endothelial damage and hypercoagulability despite pharmacological thromboprophylaxis.
Kelliher S; Weiss L; Cullivan S; O'Rourke E; Murphy CA; Toolan S; Lennon Á; Szklanna PB; Comer SP; Macleod H; Le Chevillier A; Gaine S; O'Reilly KMA; McCullagh B; Stack J; Maguire PB; Ní Áinle F; Kevane B
J Thromb Haemost; 2022 Apr; 20(4):1008-1014. PubMed ID: 35102689
[TBL] [Abstract][Full Text] [Related]
13. Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial.
Barco S; Bingisser R; Colucci G; Frenk A; Gerber B; Held U; Mach F; Mazzolai L; Righini M; Rosemann T; Sebastian T; Spescha R; Stortecky S; Windecker S; Kucher N
Trials; 2020 Sep; 21(1):770. PubMed ID: 32907635
[TBL] [Abstract][Full Text] [Related]
14. Venous thrombosis, thromboembolism, biomarkers of inflammation, and coagulation in coronavirus disease 2019.
Thondapu V; Montes D; Rosovsky R; Dua A; McDermott S; Lu MT; Ghoshhajra B; Hoffmann U; Gerhard-Herman MD; Hedgire S
J Vasc Surg Venous Lymphat Disord; 2021 Jul; 9(4):835-844.e4. PubMed ID: 33188961
[TBL] [Abstract][Full Text] [Related]
15. COVID-19-associated coagulopathy and disseminated intravascular coagulation.
Asakura H; Ogawa H
Int J Hematol; 2021 Jan; 113(1):45-57. PubMed ID: 33161508
[TBL] [Abstract][Full Text] [Related]
16. Incidence of thrombotic complications in critically ill ICU patients with COVID-19.
Klok FA; Kruip MJHA; van der Meer NJM; Arbous MS; Gommers DAMPJ; Kant KM; Kaptein FHJ; van Paassen J; Stals MAM; Huisman MV; Endeman H
Thromb Res; 2020 Jul; 191():145-147. PubMed ID: 32291094
[TBL] [Abstract][Full Text] [Related]
17. Primary thromboprophylaxis in a patient with type 3 von Willebrand disease and severe COVID-19 infection.
Vagrecha A; Stanco J; Majeed S; Kouides P; Acharya SS
Haemophilia; 2021 Jul; 27(4):e517-e519. PubMed ID: 33427345
[No Abstract] [Full Text] [Related]
18. Anticoagulation for COVID-19 Patients: A Bird's-Eye View.
Kreidieh F; Temraz S
Clin Appl Thromb Hemost; 2021; 27():10760296211039288. PubMed ID: 34595937
[TBL] [Abstract][Full Text] [Related]
19. Compression stockings in addition to low-molecular-weight heparin to prevent venous thromboembolism in surgical inpatients requiring pharmacoprophylaxis: the GAPS non-inferiority RCT.
Shalhoub J; Lawton R; Hudson J; Baker C; Bradbury A; Dhillon K; Everington T; Gohel MS; Hamady Z; Hunt BJ; Stansby G; Warwick D; Norrie J; Davies AH
Health Technol Assess; 2020 Dec; 24(69):1-80. PubMed ID: 33275096
[TBL] [Abstract][Full Text] [Related]
20. Thrombosis in COVID 2022: An Updated Narrative Review of Current Literature and Inpatient Management.
Muthiah A; Ohnigian S; Reagan JL; Hsu A
R I Med J (2013); 2022 Aug; 105(6):36-40. PubMed ID: 35881999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
